Danziger Asaf
- SEC CIK
- 0001654435
No open-market purchases or sales filed in the past year.
Current role at each company
- NVCR NovoCure LtdDirectoras of Jul 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Danziger Asaf as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 (view filing) | Jan 5 | 4 days | Danziger AsafChief Executive Officer | SSale | −212.5K | $108.73 | −$23.1M | −94.0%13.6K after | 10 lots |
| Nov 29, 2021 (view filing) | Nov 26 | 3 days | Danziger AsafChief Executive Officer | PPurchase | +4.97K | $102.44 | +$509.5K | +59.9%13.3K after | 3 lots |